Thank You!
Now in its 6th year, our annual TVM Capital Life Science Autumn Conference 2017 was held on Monday, September 18th in Montreal.
This year, our invitation-only conference was attended by 200 international participants from Asia, the United States and Europe who joined us to network with senior decision makers from biotech and pharmaceutical companies as well as venture capital groups to discuss latest trends in our industry as well as share expertiese and experience. We thank all attendants, speakers and the sponsors of our conference for lively discussions and interesting insights. Please see our news release to learn more.
Agenda |
|
| 11.30am | Registration and light lunch |
| 12.30pm | Welcome Address Hubert Birner, Managing Partner, TVM Capital Life Science |
| 12.45pm | Keynote Speaker Marc de Garidel – Chairman, IPSEN Introduction: Vanessa Grant, Norton Rose Fulbright |
| 13.30pm | Keynote Speaker Andrew Dahlem, Vice President, COO, Lilly Research Laboratories/LRL Europe Introduction: Daniel Parera, Executive-in-Residence, TVM Capital Life Science |
| 2.15pm | Panel Discussion: New Models in Venture Capital Moderator: Luc Marengere, Managing Partner, TVM Capital Life Science Panellists: Peter van der Velden – Managing General Partner, Lumira Capital Jean-Francois Leprince – Managing Partner, CtI Life Sciences Barbara Dalton – Vice President Venture Capital, Pfizer Didier Leconte – Senior Investment Director, Fonds de solidarité FTQ David Hirsch - Managing Director and Founder, Longitude Capital |
| 3.00pm | New members of the TVM Capital Life Science Portfolio – An Introduction Arndt Rolfs – CEO and founder, Centogene, Berlin Gabriel Robichaud – President and co-founder, Panthera Dental, Quebec City |
| 3.45pm | Coffee Break |
| 4.15pm | Panel Discussion: Orphan Drugs & Rare Diseases Moderator: Marc Rivière, General Partner, TVM Capital Life Science Panellists: Clarissa Desjardins – CEO, Clementia Pharmaceuticals Angela Genge – Medical Director, Clinical Research Unit and ALS Clinic, Neurological Institute and Hospital Robert Steiner - Chief Medical Officer, Acer Therapeutics Stacy Coen - Head of Rare Disease Business Development and Licensing, Sanofi |
| 5.00pm | “A Macro Economic View” Nils Behnke - Director, Bain & Company Introduction: Hubert Birner, Managing Partner, TVM Capital Life Science |
| 5.45pm | Wrap up and Outlook Luc Marengere, Managing Partner, TVM Capital Life Science |
| 6.00pm | Networking Reception: Salon Paloma Picasso |
